annual cash & cash equivalents:
$8.06B+$1.24B(+18.17%)Summary
- As of today (May 20, 2025), IX annual cash & cash equivalents is $8.06 billion, with the most recent change of +$1.24 billion (+18.17%) on March 1, 2025.
- During the last 3 years, IX annual cash & cash equivalents has risen by +$240.63 million (+3.08%).
- IX annual cash & cash equivalents is now -35.14% below its all-time high of $12.43 billion, reached on March 31, 2018.
Performance
IX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$8.06B+$946.45M(+13.30%)Summary
- As of today (May 20, 2025), IX quarterly cash & cash equivalents is $8.06 billion, with the most recent change of +$946.45 million (+13.30%) on March 1, 2025.
- Over the past year, IX quarterly cash & cash equivalents has increased by +$1.24 billion (+18.17%).
- IX quarterly cash & cash equivalents is now -35.14% below its all-time high of $12.43 billion, reached on March 31, 2018.
Performance
IX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.2% | +18.2% |
| 3 y3 years | +3.1% | +3.1% |
| 5 y5 years | -11.3% | -11.3% |
IX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.8% | +18.2% | -12.8% | +31.6% |
| 5 y | 5-year | -12.8% | +18.2% | -27.9% | +31.6% |
| alltime | all time | -35.1% | +509.0% | -35.1% | +935.5% |
IX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $8.06B(+18.2%) | $8.06B(+13.3%) |
| Dec 2024 | - | $7.12B(-13.0%) |
| Sep 2024 | - | $8.18B(+32.7%) |
| Jun 2024 | - | $6.17B(-9.6%) |
| Mar 2024 | $6.82B(-26.2%) | $6.82B(+6.4%) |
| Dec 2023 | - | $6.41B(+4.7%) |
| Sep 2023 | - | $6.13B(-3.8%) |
| Jun 2023 | - | $6.37B(-31.1%) |
| Mar 2023 | $9.25B(+18.2%) | $9.25B(+27.4%) |
| Dec 2022 | - | $7.25B(+13.2%) |
| Sep 2022 | - | $6.41B(+2.3%) |
| Jun 2022 | - | $6.26B(-19.9%) |
| Mar 2022 | $7.82B(-9.3%) | $7.82B(+0.5%) |
| Dec 2021 | - | $7.79B(-15.4%) |
| Sep 2021 | - | $9.21B(+1.5%) |
| Jun 2021 | - | $9.07B(+5.2%) |
| Mar 2021 | $8.62B(-5.2%) | $8.62B(-10.9%) |
| Dec 2020 | - | $9.68B(-13.5%) |
| Sep 2020 | - | $11.19B(+14.1%) |
| Jun 2020 | - | $9.81B(+7.9%) |
| Mar 2020 | $9.09B(-13.2%) | $9.09B(+9.7%) |
| Dec 2019 | - | $8.29B(-8.9%) |
| Sep 2019 | - | $9.09B(-4.4%) |
| Jun 2019 | - | $9.51B(-9.2%) |
| Mar 2019 | $10.47B(-15.8%) | $10.47B(-5.0%) |
| Dec 2018 | - | $11.02B(+9.8%) |
| Sep 2018 | - | $10.04B(-9.7%) |
| Jun 2018 | - | $11.12B(-10.6%) |
| Mar 2018 | $12.43B(+33.7%) | $12.43B(+13.7%) |
| Dec 2017 | - | $10.94B(+3.7%) |
| Sep 2017 | - | $10.54B(-0.9%) |
| Jun 2017 | - | $10.64B(+14.4%) |
| Mar 2017 | $9.30B(+43.1%) | $9.30B(+14.9%) |
| Dec 2016 | - | $8.09B(-14.8%) |
| Sep 2016 | - | $9.50B(+16.0%) |
| Jun 2016 | - | $8.19B(+26.1%) |
| Mar 2016 | $6.50B(-5.7%) | $6.50B(-3.3%) |
| Dec 2015 | - | $6.72B(-15.1%) |
| Sep 2015 | - | $7.92B(+9.5%) |
| Jun 2015 | - | $7.23B(+4.9%) |
| Mar 2015 | $6.89B(-13.3%) | $6.89B(+5.0%) |
| Dec 2014 | - | $6.56B(-14.5%) |
| Sep 2014 | - | $7.68B(-8.5%) |
| Jun 2014 | - | $8.39B(+5.6%) |
| Mar 2014 | $7.95B(-10.3%) | $7.95B(+17.4%) |
| Dec 2013 | - | $6.77B(-6.6%) |
| Sep 2013 | - | $7.25B(-3.1%) |
| Jun 2013 | - | $7.48B(-15.6%) |
| Mar 2013 | $8.86B | $8.86B(+10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $8.00B(-14.7%) |
| Sep 2012 | - | $9.38B(+18.2%) |
| Jun 2012 | - | $7.94B(-19.5%) |
| Mar 2012 | $9.85B(+11.2%) | $9.85B(+14.3%) |
| Dec 2011 | - | $8.62B(-7.0%) |
| Sep 2011 | - | $9.28B(+7.5%) |
| Jun 2011 | - | $8.63B(-2.6%) |
| Mar 2011 | $8.86B(+29.6%) | $8.86B(+18.3%) |
| Dec 2010 | - | $7.49B(-16.6%) |
| Sep 2010 | - | $8.98B(+29.7%) |
| Jun 2010 | - | $6.92B(+1.2%) |
| Mar 2010 | $6.84B(+47.0%) | $6.84B(-6.7%) |
| Dec 2009 | - | $7.33B(+10.4%) |
| Sep 2009 | - | $6.64B(+51.1%) |
| Jun 2009 | - | $4.39B(-5.6%) |
| Mar 2009 | $4.65B(+45.4%) | $4.65B(+8.4%) |
| Dec 2008 | - | $4.29B(+39.3%) |
| Sep 2008 | - | $3.08B(+36.4%) |
| Jun 2008 | - | $2.26B(-29.4%) |
| Mar 2008 | $3.20B(+74.9%) | $3.20B(+45.5%) |
| Dec 2007 | - | $2.20B(-1.0%) |
| Sep 2007 | - | $2.22B(+43.5%) |
| Jun 2007 | - | $1.55B(-15.4%) |
| Mar 2007 | $1.83B(-14.3%) | $1.83B(+70.7%) |
| Dec 2006 | - | $1.07B(-12.5%) |
| Sep 2006 | - | $1.22B(-6.1%) |
| Jun 2006 | - | $1.30B(-39.0%) |
| Mar 2006 | $2.14B(+48.7%) | $2.14B(+78.8%) |
| Dec 2005 | - | $1.19B(-26.3%) |
| Sep 2005 | - | $1.62B(+15.5%) |
| Jun 2005 | - | $1.40B(-2.3%) |
| Mar 2005 | $1.44B(-2.0%) | $1.44B(+84.4%) |
| Dec 2004 | - | $778.72M(-30.3%) |
| Sep 2004 | - | $1.12B(-14.4%) |
| Jun 2004 | - | $1.31B(-10.9%) |
| Mar 2004 | $1.47B(-14.4%) | $1.47B(-1.5%) |
| Dec 2003 | - | $1.49B(-2.2%) |
| Sep 2003 | - | $1.52B(+8.7%) |
| Jun 2003 | - | $1.40B(-18.3%) |
| Mar 2003 | $1.71B(-35.9%) | $1.71B(+23.4%) |
| Dec 2002 | - | $1.39B(-19.7%) |
| Sep 2002 | - | $1.73B(-35.3%) |
| Mar 2002 | $2.67B(+101.7%) | $2.67B(+51.9%) |
| Sep 2001 | - | $1.76B(+32.8%) |
| Mar 2001 | $1.32B(-48.5%) | $1.32B(-7.1%) |
| Sep 2000 | - | $1.43B(-44.6%) |
| Mar 2000 | $2.57B(+15.4%) | $2.57B |
| Mar 1999 | $2.23B(+10.6%) | - |
| Mar 1998 | $2.02B | - |
FAQ
- What is ORIX annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ORIX?
- What is ORIX annual cash & cash equivalents year-on-year change?
- What is ORIX quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for ORIX?
- What is ORIX quarterly cash & cash equivalents year-on-year change?
What is ORIX annual cash & cash equivalents?
The current annual cash & cash equivalents of IX is $8.06B
What is the all time high annual cash & cash equivalents for ORIX?
ORIX all-time high annual cash & cash equivalents is $12.43B
What is ORIX annual cash & cash equivalents year-on-year change?
Over the past year, IX annual cash & cash equivalents has changed by +$1.24B (+18.17%)
What is ORIX quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IX is $8.06B
What is the all time high quarterly cash & cash equivalents for ORIX?
ORIX all-time high quarterly cash & cash equivalents is $12.43B
What is ORIX quarterly cash & cash equivalents year-on-year change?
Over the past year, IX quarterly cash & cash equivalents has changed by +$1.24B (+18.17%)